Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
Pembrolizumab
Tag: pembrolizumab
BioInvent’s CMO comments on phase I/IIa data with BI-1808
27 June, 2023
Ultimovacs’ malignant melanoma study fully recruited
1 July, 2022
BioInvent delivers in 2021; more to come in 2022
25 February, 2022
Ultimovacs strengthens clinical validation of UV1 in Q2
25 August, 2021
Ultimovacs on track to develop universal cancer vaccine
24 September, 2020